Gpr55 deficiency crucially alters cardiomyocyte homeostasis and counteracts angiotensin II induced maladaption in female mice.
Br J Pharmacol
2025
182
3
670-691
Evaluation of deceased-donor kidney offers: development and validation of novel data driven and expert based prediction models for early transplant outcomes.
Front Immunol
2025
15
Potential and Uncertainties of RejectClass in Acute Kidney Graft Dysfunction: An Independent Validation Study.
Transplantation
2024
108
5
1228-1238
Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trial.
Eur J Heart Fail
2024
26
4
963-970
Acute and chronic complication profiles among patients with chronic kidney disease in Alberta, Canada: a retrospective observational study.
BMC Nephrol
2024
25
1
Development and validation of a chronic kidney disease progression model using patient-level simulations.
Ren Fail
2024
46
2
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
N Engl J Med
2025
392
8
777-787
Molecular insights into P2X signalling cascades in acute kidney injury.
Purinergic Signal
2024
20
5
477-486
FrozONE: quick cell nucleus enrichment for comprehensive proteomics analysis of frozen tissues.
Life Sci Alliance
2025
8
3
Effect of Avenciguat on Albuminuria in Patients with CKD: Two Randomized Placebo-Controlled Trials.
J Am Soc Nephrol
2024
35
9
1227-1239